Difference between revisions of "Team:San Andres/Software"
Line 2: | Line 2: | ||
<head data-gwd-animation-mode="quickMode"> | <head data-gwd-animation-mode="quickMode"> | ||
+ | <meta charset="utf-8"> | ||
+ | <title>wik</title> | ||
+ | <meta name="generator" content="Google Web Designer 1.4.1.0901"> | ||
+ | <style type="text/css"> | ||
+ | html, body { | ||
+ | width: 100%; | ||
+ | height: 100%; | ||
+ | margin: 0px; | ||
+ | } | ||
+ | body { | ||
+ | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | background-color: transparent; | ||
+ | } | ||
+ | </style> | ||
</head> | </head> | ||
<body> | <body> | ||
+ | <title><endnote><head> <title><endnote><head> <meta> <title> | ||
+ | </title> | ||
+ | <title>wiki</title> | ||
+ | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | ||
+ | <meta name="generator" content="Google Web Designer 1.3.2.0521"> | ||
+ | <style type="text/css"> | ||
+ | html, body { | ||
+ | width: 100%; | ||
+ | height: 100%; | ||
+ | margin: 0px; | ||
+ | } | ||
+ | body { | ||
+ | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | } | ||
+ | </style> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <title>wiki</title> | ||
+ | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | ||
+ | <meta name="generator" content="Google Web Designer 1.3.2.0521"> | ||
+ | <style type="text/css"> | ||
+ | html, body { | ||
+ | width: 100%; | ||
+ | height: 100%; | ||
+ | margin: 0px; | ||
+ | } | ||
+ | body { | ||
+ | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | background-color: transparent; | ||
+ | } | ||
+ | </style> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
+ | <title></title> | ||
+ | <title>exp</title> | ||
+ | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | ||
+ | <meta name="generator" content="Google Web Designer 1.3.2.0521"> | ||
+ | <style type="text/css"> | ||
+ | html, body { | ||
+ | width: 100%; | ||
+ | height: 100%; | ||
+ | margin: 0px; | ||
+ | } | ||
+ | body { | ||
+ | -webkit-transform: perspective(1400px) matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
+ | background-color: transparent; | ||
+ | } | ||
+ | </style> | ||
<meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | <meta http-equiv="content-type" content="text/html; charset=ISO-8859-1"> | ||
<title></title> | <title></title> | ||
Line 71: | Line 154: | ||
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"> | ||
<meta name="generator" content="Google Web Designer 1.3.2.0521"> | <meta name="generator" content="Google Web Designer 1.3.2.0521"> | ||
− | <img style="width: 962px; height: 325px;" src="https://static.igem.org/mediawiki/2015/thumb/8/8b/Gluten-s-Job.jpeg/800px-Gluten-s-Job.jpeg" alt="File:Gluten-s-Job.jpeg | + | <img style="width: 962px; height: 325px;" src="https://static.igem.org/mediawiki/2015/thumb/8/8b/Gluten-s-Job.jpeg/800px-Gluten-s-Job.jpeg" alt="File:Gluten-s-Job.jpeg"> |
<style type="text/css" class=""> | <style type="text/css" class=""> | ||
html, body { | html, body { | ||
Line 182: | Line 265: | ||
.gwd-a-1thu { | .gwd-a-1thu { | ||
color: rgb(0, 0, 0); | color: rgb(0, 0, 0); | ||
− | |||
− | |||
background-image: none; | background-image: none; | ||
background-color: rgb(255, 255, 255); | background-color: rgb(255, 255, 255); | ||
Line 471: | Line 552: | ||
-webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0.05, 0, 0, 1); | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0.05, 0, 0, 1); | ||
-webkit-transform-style: preserve-3d; | -webkit-transform-style: preserve-3d; | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
} | } | ||
.gwd-img-n53q { | .gwd-img-n53q { | ||
Line 497: | Line 572: | ||
} | } | ||
.gwd-a-36ww { | .gwd-a-36ww { | ||
− | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, | + | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, -16.1, 0.05, 0, 1); |
-webkit-transform-style: preserve-3d; | -webkit-transform-style: preserve-3d; | ||
} | } | ||
Line 508: | Line 583: | ||
top: 349.384236453212px; | top: 349.384236453212px; | ||
width: 250px; | width: 250px; | ||
+ | } | ||
+ | .gwd-img-zpsn { | ||
+ | position: absolute; | ||
+ | width: 150px; | ||
+ | left: -165.73913043478px; | ||
+ | top: 49.3260869565235px; | ||
+ | } | ||
+ | .gwd-a-d01x { | ||
+ | -webkit-transform: matrix3d(1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1, 0, 0, 0, 0, 1); | ||
+ | -webkit-transform-style: preserve-3d; | ||
} | } | ||
</style> | </style> | ||
<!--navigation menu --> | <!--navigation menu --> | ||
+ | <br> | ||
<meta charset="utf-8"> | <meta charset="utf-8"> | ||
<title>wiki</title> | <title>wiki</title> | ||
Line 531: | Line 617: | ||
header { | header { | ||
margin-top: 10px; | margin-top: 10px; | ||
− | |||
overflow: hidden; | overflow: hidden; | ||
height: 150px; | height: 150px; | ||
position: relative; | position: relative; | ||
− | + | width: 120%; | |
− | -webkit-transform: translate3d(- | + | -webkit-transform: translate3d(-137px, -14px, 0px); |
-webkit-transform-style: preserve-3d; | -webkit-transform-style: preserve-3d; | ||
} | } | ||
nav { | nav { | ||
+ | top: -20px; | ||
position: absolute; | position: absolute; | ||
+ | left: 0px; | ||
right: 0px; | right: 0px; | ||
margin: 20px auto; | margin: 20px auto; | ||
max-width: 1000px; | max-width: 1000px; | ||
width: 90%; | width: 90%; | ||
− | |||
− | |||
} | } | ||
nav ul { | nav ul { | ||
Line 606: | Line 691: | ||
nav > ul > li > a:hover > span { | nav > ul > li > a:hover > span { | ||
top: 0px; | top: 0px; | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
} | } | ||
</style> | </style> | ||
Line 683: | Line 732: | ||
<div class="gwd-div-7xzo gwd-a-1thu"> | <div class="gwd-div-7xzo gwd-a-1thu"> | ||
<h1>Abstract</h1> | <h1>Abstract</h1> | ||
− | <big>The celiac disease affects 1 in 265 people worldwide and 15% | + | <div style="text-align: justify;"><big>The celiac |
+ | disease affects 1 in 265 people worldwide and 15% | ||
of population in Chile. This in an irreversible autoimmune disease in | of population in Chile. This in an irreversible autoimmune disease in | ||
which due to the presence of genes HLA DQ2 or HLA DQ8 in those | which due to the presence of genes HLA DQ2 or HLA DQ8 in those | ||
Line 690: | Line 740: | ||
causing multiple effects in the organism (diarrhea, constipation, porr | causing multiple effects in the organism (diarrhea, constipation, porr | ||
absorption, among others) significantly affecting their quatily of life.</big> | absorption, among others) significantly affecting their quatily of life.</big> | ||
− | + | <br> | |
− | + | <br> | |
− | Whereas the majority of the world food contains gluten, we propose a | + | <big>Whereas the majority of the world food contains gluten, we |
+ | propose a | ||
treatment for those who can't eat gluten, and can do so without | treatment for those who can't eat gluten, and can do so without | ||
problems. In detail, our project involves a system able to degrade | problems. In detail, our project involves a system able to degrade | ||
Line 700: | Line 751: | ||
improve the quality of life of all those reported with celiac disease. | improve the quality of life of all those reported with celiac disease. | ||
People who suffer from gluten intolerance have an adverse reaction to | People who suffer from gluten intolerance have an adverse reaction to | ||
− | gluten proteins found in wheat, barley, and rye products.<br> | + | gluten proteins found in wheat, barley, and rye products.</big> |
− | <br> | + | <br> |
+ | </div> | ||
+ | <big><br> | ||
</big> | </big> | ||
<div style="text-align: center;"> | <div style="text-align: center;"> | ||
Line 713: | Line 766: | ||
<br> | <br> | ||
<a href="https://2015.igem.org/Main_Page" class="gwd-a-3xpx gwd-a-36ww"> | <a href="https://2015.igem.org/Main_Page" class="gwd-a-3xpx gwd-a-36ww"> | ||
− | <img style="border: 0px solid ; width: 150px; height: 150px | + | <img style="border: 0px solid ; width: 150px; height: 150px; left: 989px; top: 49px;" alt="" src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" class="gwd-img-kwqf"> |
</a> | </a> | ||
− | <a href="https://igem.org/Team_List?year=2015" class="gwd-a-3xpx"> | + | <a href="https://igem.org/Team_List?year=2015" class="gwd-a-3xpx gwd-a-d01x"> |
− | <img src="https://static.igem.org/mediawiki/2015/thumb/ | + | <img src="https://static.igem.org/mediawiki/2015/thumb/8/85/Logo_Definitvo.png/654px-Logo_Definitvo.png" class="gwd-img-zpsn"> |
</a> | </a> | ||
+ | <br> | ||
+ | <br> | ||
+ | <br> | ||
<br> | <br> | ||
<br> | <br> |
Revision as of 16:15, 14 September 2015
Abstract
The celiac
disease affects 1 in 265 people worldwide and 15%
of population in Chile. This in an irreversible autoimmune disease in
which due to the presence of genes HLA DQ2 or HLA DQ8 in those
affected, the consumption of foods containing gluten (all fods derived
from wheat, barley, rye, etc.) cause an inflammation in small intestine
causing multiple effects in the organism (diarrhea, constipation, porr
absorption, among others) significantly affecting their quatily of life.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.
Whereas the majority of the world food contains gluten, we propose a treatment for those who can't eat gluten, and can do so without problems. In detail, our project involves a system able to degrade gluten via the enzyme KumaMax and report the operation simultaneously with a red fluorescent protein. The foregoing, works in a genetically modified E. coli bacteria. With this project, in long run, we hope to improve the quality of life of all those reported with celiac disease. People who suffer from gluten intolerance have an adverse reaction to gluten proteins found in wheat, barley, and rye products.